Which statins require dose adjustment based on glomerular filtration rate (GFR)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Which Statins Require GFR-Based Dose Adjustment

Three statins require dose adjustment based on GFR: rosuvastatin, lovastatin, and simvastatin, while fluvastatin requires caution in severe kidney disease. 1

Statins Requiring Dose Adjustment

Rosuvastatin

  • GFR ≥30 mL/min: No dose adjustment needed for mild to moderate kidney disease
  • GFR <30 mL/min (not on hemodialysis):
    • Start at 5 mg daily
    • Maximum dose: 10 mg daily 1

This is the most restrictive dosing requirement among commonly used statins.

Lovastatin

  • GFR ≥30 mL/min: Standard dosing (10-80 mg daily)
  • **GFR <30 mL/min**: Use doses >20 mg daily cautiously 1

Simvastatin

  • Severe kidney disease: Initiate therapy at 5 mg daily 1

Fluvastatin

  • Mild to moderate kidney disease: No adjustment needed
  • Severe kidney disease: Use caution; not studied at doses >40 mg in these patients 1

Statins NOT Requiring Dose Adjustment

Atorvastatin

  • No dosage adjustment needed regardless of GFR 1
  • Prescribing information confirms no adjustment required for kidney disease 2

Pravastatin

  • No dosage adjustment needed at any GFR level 1

Clinical Context and Important Caveats

The KDIGO 2013 guideline recommends avoiding high-intensity statins in patients with eGFR <60 mL/min/1.73 m² 2. This recommendation is based on:

  • Reduced renal excretion (true for some statins)
  • Increased polypharmacy and comorbidity in CKD patients
  • Doses used in CKD clinical trials

However, this creates a clinical dilemma: the ACC/AHA guidelines recommend high-intensity statins for acute coronary syndrome patients, while KDIGO suggests dose reduction in CKD 2. In practice, atorvastatin and pravastatin offer the advantage of no required dose adjustment, making them preferred choices when higher doses are needed in CKD patients.

Safety data from large trials (4D, AURORA, SHARP) showed no excess toxicity with statins in advanced CKD and dialysis patients 1, 3, suggesting statins remain safe even in severe kidney disease when appropriately dosed.

Practical Algorithm

  1. For GFR ≥60 mL/min: Use any statin at standard doses
  2. For GFR 30-59 mL/min:
    • Prefer atorvastatin or pravastatin (no adjustment needed)
    • If using rosuvastatin, lovastatin, or simvastatin, follow dose restrictions above
  3. For GFR <30 mL/min:
    • Rosuvastatin: Start 5 mg, max 10 mg daily
    • Lovastatin: Limit to ≤20 mg daily
    • Simvastatin: Start at 5 mg daily
    • Atorvastatin/pravastatin: No adjustment needed

Key pitfall: Don't routinely discontinue statins when GFR declines below 30 mL/min—adjust the dose or switch to a statin not requiring adjustment rather than stopping therapy entirely, as cardiovascular protection remains important 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.